Literature DB >> 3359846

Histoplasmosis in patients at risk for the acquired immunodeficiency syndrome in a nonendemic setting.

S H Salzman1, R L Smith, C P Aranda.   

Abstract

We reviewed 18 cases of histoplasmosis in patients at risk for the acquired immunodeficiency syndrome seen at two New York City hospitals in the past 3 1/2 years. Seventeen patients were Hispanic, including 13 born in Puerto Rico and three in South America. Clinical presentation was subacute, with high fever, weight loss, and mild respiratory symptoms with well-maintained gas exchange. Five patients had normal chest roentgenograms. The most common chest roentgenographic abnormality was diffuse small nodules. A rapid diagnosis was established histologically in 72 percent of patients, most commonly by transbronchial lung biopsy; cultures were positive in 94 percent of patients while serology was positive in five of six patients. Mycobacterium tuberculosis was a concurrent, often unrecognized, pathogen in six cases. Most patients responded to amphotericin therapy. Histoplasmosis may represent an early sign of altered host immunity in the acquired immunodeficiency syndrome.

Entities:  

Mesh:

Year:  1988        PMID: 3359846     DOI: 10.1378/chest.93.5.916

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

1.  Acute histoplasmosis acquired in Mexico.

Authors:  C M Kirsch; W A Jensen; F T Kagawa; A C Campagna
Journal:  West J Med       Date:  1994-03

2.  Bronchoscopic findings in a case of bronchopulmonary histoplasmosis.

Authors:  B Kneale; C Turton
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

3.  [A case of AIDS-associated histoplasmosis in Germany].

Authors:  J K Rockstroh; A Hachmann; E Molitor; K Tschubel; G Marklein; W Luster; S Ewig
Journal:  Klin Wochenschr       Date:  1991-05-03

Review 4.  New challenges to the therapy of systemic fungal infections.

Authors:  G Medoff
Journal:  Trans Am Clin Climatol Assoc       Date:  1996

5.  Antifungal mechanisms of activated murine bronchoalveolar or peritoneal macrophages for Histoplasma capsulatum.

Authors:  E Brummer; D A Stevens
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

Review 6.  Histoplasmosis capsulati and duboisii in Europe: the impact of the HIV pandemic, travel and immigration.

Authors:  R Manfredi; A Mazzoni; A Nanetti; F Chiodo
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

Review 7.  Endemic mycosis complicating human immunodeficiency virus infection.

Authors:  G A Sarosi; S F DAvies
Journal:  West J Med       Date:  1996-04

Review 8.  Pulmonary complications of AIDS: a clinical strategy.

Authors:  J D Edelson; R H Hyland
Journal:  CMAJ       Date:  1989-06-01       Impact factor: 8.262

Review 9.  Emerging disease issues and fungal pathogens associated with HIV infection.

Authors:  N M Ampel
Journal:  Emerg Infect Dis       Date:  1996 Apr-Jun       Impact factor: 6.883

10.  Treating progressive disseminated histoplasmosis in people living with HIV.

Authors:  Marylou Murray; Paul Hine
Journal:  Cochrane Database Syst Rev       Date:  2020-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.